Physician profile
Patrick Gomella
NPI 1093058315
$4,557.09
in general payments reported to CMS, 2019-2025
20 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $238 · 2023: $3,318 · 2024: $816 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,589 · Travel and Lodging: $1,730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,588.85 |
| Travel and Lodging | $1,730.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $3,303.56 | 2023-2025 | Nanoknife |
| Teleflex LLC | $344.75 | 2022-2024 | Urolift |
| Edap Technomed INC | $109.89 | 2023 | |
| Convatec INC. | $96.20 | 2022-2024 | |
| Boston Scientific Corporation | $90.42 | 2022-2024 | Rezum Generator |
| Sumitomo Pharma America, INC. | $85.83 | 2023-2024 | Gemtesa |
| Galvanize Therapeutics, INC | $74.46 | 2025 | Aliya System |
| Cook Medical LLC | $69.06 | 2022 | |
| Progenics Pharmaceuticals, INC. | $56.87 | 2024-2025 | |
| Photocure INC | $46.76 | 2023 | Cysview |
| Dentsply Ih Ab | $41.48 | 2023 | Lofric |
| Urovant Sciences INC | $40.91 | 2022 | |
| Medtronic, INC. | $38.65 | 2023 | Interstim |
| Smith+Nephew, INC. | $31.77 | 2024 | Stravix |
| Merck Sharp & Dohme LLC | $28.19 | 2023 | Lynparza, Keytruda |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $22.13 | 2025 | Erleada |
| Astrazeneca Pharmaceuticals LP | $21.62 | 2023 | Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $21.60 | 2023 | |
| Abbvie INC. | $18.56 | 2023 | |
| Coloplast Corp | $14.38 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Gomella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.